DOI:
10.1055/s-00000020
Geburtshilfe und Frauenheilkunde
LinksClose Window
References
Hurvitz SA, Martin M, Jung KH. et al.
Neoadjuvant Trastuzumab Emtansine and Pertuzumab in Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: Three-Year Outcomes From the Phase III KRISTINE Study.
J Clin Oncol 2019;
DOI: 10.1200/JCO.19.00882.
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.